STAT3 and colorectal carcinoma: It activates the NF-κB/miR-132 axis, promoting M2 macrophage polarization and CRC metastasis, as well as TLR4/IL-6/p-STAT3/c-MYC pathways to enhance immunosuppressive effects (107–110).